Our laboratory has the control and standardisation responsibilities for antithrombotics, coagulation factors and inhibitors to aid correct diagnosis and safe and effective treatment of bleeding and thrombotic disorders. An active research and development programme is in place to underpin the control and standardisation remits.
We produce World Health Organisation (WHO) International Standards, pharmacopeial standards, British working standards and NIBSC reagents.
In the diagnostics area these are:
In the reference reagents area these are:
Batch release of high purity FIX, Prothrombin Complex Concentrates and Antithrombin under Article 114 of Directive 2001/83/EC as amended by Directive 2004/27/EC, in compliance to ISO/IEC 17025, with independent accreditation by the United Kingdom Accreditation Service (UKAS).
Our activities are:
For new generation FVIII and FIX therapeutics:
For anticoagulant and non-anticoagulant activities of heparin and related polysaccharides:
For procoagulant activities of immunoglobulin products:
Dr Helen WilmotJohn HogwoodStella Williams